Investor profile
DxAngels
Angel syndicate
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
DxAngels is an investment syndicate of Doximity alumni, physicians, and health tech leaders that invests $300k–$500k in seed and Series A digital health startups. The syndicate prefers companies that have moved beyond initial stages of product-market fit and are looking to scale, pairing capital with the combined expertise of dozens of Doximity alumni, tech-forward physicians, and health tech leaders. The founding team — Ahmed Belal, Mujtaba Badat, and Dr. Peter Alperin — were all early employees at Doximity (NYSE: DOCS), where they helped build the largest medical network in the U.S. Their family office vehicle, Belal Badat Ventures, also writes angel checks into digital health startups from conception to growth stage, broadening the syndicate's stage coverage.
Notable quotes
“Our syndicate prefers companies that have moved beyond initial stages of product-market fit and are looking to scale.”
“The investment comes with the combined brain power and experience of dozens of Doximity alumni, tech-forward physicians, and health tech leaders who want to help founders grow their businesses.”
Team
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Italic Health | Seed | — | 2026-01-16 |
| Mishe Health | Seed | — | 2025-01-01 |
| Maya AI | Seed | — | 2024-07-01 |
| Syndicate Bio | Seed | — | 2024-10-01 |
| Medzoomer | Seed | — | 2024-08-01 |
| RefAssured | Seed | $3m | — |
| Pulse Charter Connect | Seed | — | 2023-12-01 |
| Flourish Health | Seed | — | 2023-06-01 |
| Wellnite | Seed | — | 2022-05-01 |
| Krewe Anesthesia | Seed | — | 2024-01-01 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Alumni Ventures | 2 |
| HighSage Ventures | 2 |
| Bullhorn Ventures | 1 |
| Dogwood Ventures | 1 |
| Flex Capital | 1 |
| Mana Ventures | 1 |
Fit check
Is DxAngels a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit